DekaBank Deutsche Girozentrale lessened its stake in shares of Cigna Group (NYSE:CI - Free Report) by 0.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 191,483 shares of the health services provider's stock after selling 1,371 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.07% of Cigna Group worth $62,231,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Flaharty Asset Management LLC purchased a new stake in Cigna Group during the 1st quarter valued at $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the first quarter worth $29,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock worth $30,000 after acquiring an additional 72 shares during the period. Princeton Global Asset Management LLC increased its position in Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider's stock valued at $32,000 after acquiring an additional 52 shares during the last quarter. Finally, Retirement Wealth Solutions LLC lifted its holdings in Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock valued at $33,000 after acquiring an additional 43 shares during the period. 86.99% of the stock is currently owned by institutional investors.
Cigna Group Stock Up 0.2%
Shares of CI stock opened at $307.42 on Wednesday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $350.00. The company's fifty day moving average price is $298.40 and its 200-day moving average price is $307.80. The company has a market capitalization of $82.06 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 0.90 and a beta of 0.45.
Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the firm posted $6.72 EPS. Cigna Group's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. Wall Street Zen cut shares of Cigna Group from a "buy" rating to a "hold" rating in a research note on Friday, October 3rd. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Cigna Group in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Guggenheim reissued a "buy" rating and set a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $369.89.
Read Our Latest Report on CI
Insider Transactions at Cigna Group
In related news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company's stock.
Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.